Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to follow and collect additional medical and developmental
information on children after histrelin subcutaneous implant therapy is discontinued.